402 related articles for article (PubMed ID: 28043130)
1. Effect of Extent of Supersaturation on the Evolution of Kinetic Solubility Profiles.
Han YR; Lee PI
Mol Pharm; 2017 Jan; 14(1):206-220. PubMed ID: 28043130
[TBL] [Abstract][Full Text] [Related]
2. Evolution of supersaturation of amorphous pharmaceuticals: the effect of rate of supersaturation generation.
Sun DD; Lee PI
Mol Pharm; 2013 Nov; 10(11):4330-46. PubMed ID: 24066837
[TBL] [Abstract][Full Text] [Related]
3. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
Sun DD; Lee PI
Mol Pharm; 2015 Apr; 12(4):1203-15. PubMed ID: 25775257
[TBL] [Abstract][Full Text] [Related]
4. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
Schver GCRM; Lee PI
Mol Pharm; 2018 May; 15(5):2017-2026. PubMed ID: 29601723
[TBL] [Abstract][Full Text] [Related]
5. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
6. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
Sun DD; Lee PI
J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
[TBL] [Abstract][Full Text] [Related]
7. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions.
Xie T; Gao W; Taylor LS
Int J Pharm; 2017 Oct; 531(1):313-323. PubMed ID: 28844901
[TBL] [Abstract][Full Text] [Related]
8. Evolution of supersaturation from amorphous solid dispersions in water-insoluble polymer carriers: Effects of swelling capacity and interplay between partition and diffusion.
Schver GCRM; Nadvorny D; Lee PI
Int J Pharm; 2020 May; 581():119292. PubMed ID: 32243967
[TBL] [Abstract][Full Text] [Related]
9. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs.
Sarode AL; Wang P; Obara S; Worthen DR
Eur J Pharm Biopharm; 2014 Apr; 86(3):351-60. PubMed ID: 24161655
[TBL] [Abstract][Full Text] [Related]
10. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
11. Amorphous solid dispersions in high-swelling, low-substituted hydroxypropyl cellulose for enhancing the delivery of poorly soluble drugs.
Danda LJA; Christinne Rocha de Medeiros Schver G; Lamartine Soares Sobrinho J; Lee PI; Felts de La Roca Soares M
Int J Pharm; 2023 Jul; 642():123122. PubMed ID: 37307959
[TBL] [Abstract][Full Text] [Related]
12. Haste Makes Waste: The Interplay Between Dissolution and Precipitation of Supersaturating Formulations.
Sun DD; Lee PI
AAPS J; 2015 Nov; 17(6):1317-26. PubMed ID: 26338234
[TBL] [Abstract][Full Text] [Related]
13. Combining amorphous solid dispersions for improved kinetic solubility of posaconazole simultaneously released from soluble PVP/VA64 and an insoluble ammonio methacrylate copolymer.
Danda LJA; Batista LM; Melo VCS; Soares Sobrinho JL; Soares MFR
Eur J Pharm Sci; 2019 May; 133():79-85. PubMed ID: 30890364
[TBL] [Abstract][Full Text] [Related]
14. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
15. Dissolution and precipitation behavior of amorphous solid dispersions.
Alonzo DE; Gao Y; Zhou D; Mo H; Zhang GGZ; Taylor LS
J Pharm Sci; 2011 Aug; 100(8):3316-3331. PubMed ID: 21607951
[TBL] [Abstract][Full Text] [Related]
16. Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.
Chen H; Pui Y; Liu C; Chen Z; Su CC; Hageman M; Hussain M; Haskell R; Stefanski K; Foster K; Gudmundsson O; Qian F
J Pharm Sci; 2018 Jan; 107(1):317-326. PubMed ID: 29107047
[TBL] [Abstract][Full Text] [Related]
17. Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and
Baghel S; Cathcart H; O'Reilly NJ
Int J Pharm; 2018 Jan; 536(1):414-425. PubMed ID: 29183857
[TBL] [Abstract][Full Text] [Related]
18. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
Jackson MJ; Kestur US; Hussain MA; Taylor LS
Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
[TBL] [Abstract][Full Text] [Related]
19. Combining in vitro dissolution/permeation with microdialysis sampling: Capabilities and limitations for biopharmaceutical assessments of supersaturating drug formulations.
Holzem FL; Jensen IH; Petrig Schaffland J; Stillhart C; Brandl M; Bauer-Brandl A
Eur J Pharm Sci; 2023 Sep; 188():106533. PubMed ID: 37480963
[TBL] [Abstract][Full Text] [Related]
20. Role of Molecular Interactions for Synergistic Precipitation Inhibition of Poorly Soluble Drug in Supersaturated Drug-Polymer-Polymer Ternary Solution.
Prasad D; Chauhan H; Atef E
Mol Pharm; 2016 Mar; 13(3):756-65. PubMed ID: 26866895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]